Berwyn biopharm firm begins mid-stage testing of experimental therapy for Alzheimer's, Parkinson's
September 01, 2020 at 10:59 AM EDT
The start of the phase-II clinical trial was temporarily delayed by the Covid-19 pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|